Pattern of calcification: intimal vs. medial, and difference below and above the knee. Aloke Finn, MD CVPath Institute Inc. Gaithersburg, MD.
|
|
- Pauline Walton
- 5 years ago
- Views:
Transcription
1 Pattern of calcification: intimal vs. medial, and difference below and above the knee Aloke Finn, MD CVPath Institute Inc. Gaithersburg, MD. USA
2 Conflict of Interest Declaration Institution grant/research support 480 Biomedical, Abbott Vascular, Atrium, BioSensors International, Biotronik, Boston Scientific, Cordis J&J, GSK, Kona, Medtronic, MicroPort Medical, CeloNova, OrbusNeich Medical, ReCore, SINO Medical Technology, Terumo Corporation, and W.L. Gore, Spectronics, CSI, Lutonix Bard, Surmodics, Microport, Meril Life Sciences Speaking Honoraria Abbott, Cook Medical
3 Talk Outline Intimal and Medial calcification in peripheral arteries Are patterns of calcification above and below the knee different and if so how? In diabetics is there excessive calcification and what type?
4 Intimal Calcification in commonly observed in SFA-POPLITIAL ARTERIES
5 Mönckeberg s Medial Calcification in Asymptomatic Individuals Ca ++ I Ca ++ M Kolodgie F, et al. ESVB 2007:49-70
6 Histologic Sections from Patients with CLI Undergoing a Lower Limb Amputation Dorsalis pedis segment with CTO neovascularization Posterior tibial artery with atheromatous thromboemboli recanalization fragmentation of elastin layer Posterior tibial artery with circumferential medial calcification Ca Ca Soor GS, et al. Pathology 2008;40:
7 Medial and Intimal calcification of the SFA PIT Intimal Calcification Medial Calcification
8 A B C D CV LEFT SFA E A B C D E F G H I J F J I H G
9 Popliteal artery Nodular calcification Ca2+ Plaque rupture with sheet calcification and propagated thrombus
10 Medial Calcification (Mönckeberg s) in dorsalis pedis artery
11 Study of Vascular calcification in human peripheral arteries Vascular calcification was assessed with five severely calcified peripheral arteries. Type of calcification: None, Microcalcification, Fragmented calcification, Sheet calcification, Nodular calcification Intimal vs. Medial calcification Bone formation 170 histologic sections (86 sections from superficial femoral artery [SFA] and 84 sections from popliteal artery) were evaluated.
12 Vascular calcification in human peripheral arteries, from 5 asymptomatic individuals Microcalcification Fragmented calcification Sheet calcification Nodular calcification
13 The relationship between % stenosis and plaque type 100% SFA+POP lesion (532 sections from 6 legs) 100% Below the knee lesion (1270 sections from 6 legs) 90% 90% 80% 80% 70% 60% 50% 40% 30% 20% 10% 0% 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 70% 60% 50% 40% 30% 20% 10% 0% n=16 n=64 0% n=76 n=73 n=59 n=60 n=66 n=42 n=25 n=51 n=502 n=68 n=68 n=73 n=56 n=59 n=69 n=88 n=106 n= % 10-20% 20-30% 30-40% 40-50% 50-60% 60-70% 70-80% 80-90% % AIT/Fibrous PIT Fibroatheroma Fibrocalcific plaque Nodular calcification TCFA Thrombus Total occlusion Fibrocalcific and nodular predominate (Rupture + Erosion) Fibrocalcific and fibroatheroma predominate
14 The relationship between % stenosis and intimal calcification pattern by histology SFA+POP lesion (369 sections from 6 legs) Below the knee lesion (1270 sections from 6 legs) 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 100% 90% 80% 70% 60% 50% 40% 30% 20% 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 10% 0% 0-20% 20-40% 40-60% 60-80% % 0-20% 20-40% 40-60% 60-80% % 0% n=71 n=87 n=72 n=69 n=70 n=569 n=125 n=76 n=82 n= % 20-40% 40-60% 60-80% % none microcalcification Fragmented Nodular calcification sheet Microcalcification and fragmented predominate Nodular and sheet calcification predominate
15 Quadrant Calcification Grade Fanelli et al. Cardiovasc Intervent Radiol (2014) 37: Calcification in 10 asymptomatic legs. (preliminary data) AK 444 lesions BK 1126 lesions Intimal Medial 65.9% 24.4% 8.9% 0.8% 90.6% 7.2% 1.9% 0.2% Intimal 81.1% 10.0% 6.9% 0.2% Medial 98.2% 1.5% 0.3% 0%
16 Peripheral vascular disease: who gets it and why? 58 patients (33 men [57%] and 25 females [43%]), age 43 to 95 years (mean 68.7±12.5 years), who underwent a lower extremity amputation (33 [57%] below knee and the rest 25 [43%] above knee) over a 2 year period (Jan 2002 to Dec 2003). 50% had extensive non-healing ulcers and 71% had gangrene, which was more frequent in diabetics (n=34) versus non-diabetics (n=8, p=0.0032). The presence of medial calcification and concomitant atherosclerosis was observed in 168 (77%) of the 218 arterial segments with atherosclerotic plaques. However, the extent of atherosclerosis did not correlate with the extent of medial calcification. Soor GS, et al. Pathology 2008;40:
17 Diabetics have greater atherosclerosis, calcification and neovascularization than non-diabetics Characteristics Diabetic Non-diabetic P valve Number of Patients Medial calcification 40 (type II 80%) % (majority having >50% medial calcification) 28.6% P<0.001 Soor GS, et al. Pathology 2008;40:
18 Conclusion Intimal Atherosclerosis Calcification is frequently observed in both coronary and peripheral artery disease Coronary arteries do not show medial calcification but it is commonly observed in patients with peripheral vascular disease. Our data suggest atherosclerotic and medical calcification is more common above the knee. The most frequent type of calcification is fragmented but sheets of calcification is most frequent in the femoral than popliteal arteries Bone formation AK is seen in 10 to 15% of patients with peripheral vascular disease. Its significance is unknown. Medial calcification is common in peripheral arteries, especially in diabetes and CKD.
19 Funding CVPath Institute Inc. Acknowledgments CVPath Institute Sho Torii, MD Kazuyuki Yahagi, MD Hiroyoshi Mori, MD Emanuel Harari, MD Elena Ladich, MD Robert Kutz, MS Ed Acampado, DVM Youhui Liang, MD Abebe Atiso, HT Jinky Beyer Lila Adams, HT Frank D Kolodgie, PhD Liang Guo, PhD Renu Virmani, MD Washington DC My afinn@cvpath.org
20 Pattern of calcification: intimal vs. medial, and difference below and above the knee Aloke Finn, MD CVPath Institute Inc. Gaithersburg, MD. USA
Comparison of particulate embolization in different DCB formulations. Aloke V. Finn, MD CVPath Institute Inc. Gaithersburg, MD.
Comparison of particulate embolization in different DCB formulations. Aloke V. Finn, MD CVPath Institute Inc. Gaithersburg, MD. USA Conflict of Interest Declaration Institution grant/research support 48
More informationDrug eluting devices: Why paclitaxel works above the knee and sirolimus below the knee, is the stent or the drug?
Drug eluting devices: Why paclitaxel works above the knee and sirolimus below the knee, is the stent or the drug? Aloke Finn, MD CVPath Institute Inc. Gaithersburg, MD. USA Conflict of Interest Declaration
More informationA study of downstream events of the two leading DCBs on the market. Aloke Finn, MD CVPath Institute Inc. Gaithersburg, MD. USA
A study of downstream events of the two leading DCBs on the market Aloke Finn, MD CVPath Institute Inc. Gaithersburg, MD. USA Disclosure Statement of Financial Interest Within the past 12 months, I or
More informationPre-clinical comparison of drug coated balloons. Renu Virmani, MD CVPath Ins5tute Inc. Gaithersburg, MD. USA
Pre-clinical comparison of drug coated balloons Renu Virmani, MD CVPath Ins5tute Inc. Gaithersburg, MD. USA Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner
More informationHow DCB drug dose effects vessel healing. Aloke Finn, MD CVPath Institute Inc. Gaithersburg, MD. USA
How DCB drug dose effects vessel healing Aloke Finn, MD CVPath Institute Inc. Gaithersburg, MD. USA Disclosure Statement of Financial Interest Speaker's name : Aloke, Finn, Gaithersburg I have the following
More informationDrug Eluting Stent DES Pathology Update What we know, what we do not know
Drug Eluting Stent DES Pathology Update What we know, what we do not know 13 th Summit TCT Asia 25 th April 2008 Renu Virmani, MD. CVPath Institute Inc. Gaithersburg, MD Disclosure Statement of Financial
More informationAtherectomy with thrombectomy of. Rotarex S : The Leipzig experience
Atherectomy with thrombectomy of femoropopliteal occlusions with Rotarex S : The Leipzig experience Dr. Bruno Freitas, Prof., MD Department of Interventional Angiology, Universität Leipzig, Germany Santa
More informationSites of Atherosclerosis In order of Frequency
Pathological Features of Peripheral Atherosclerosis: Implication for Device Development G Nakazawa Tokai Univ. Kanagawa, Japan 1 Sites of Atherosclerosis In order of Frequency carotid (3) (3) Coronary
More informationDisclosures. Talking Points. An initial strategy of open bypass is better for some CLI patients, and we can define who they are
An initial strategy of open bypass is better for some CLI patients, and we can define who they are Fadi Saab, MD, FASE, FACC, FSCAI Metro Heart & Vascular Metro Health Hospital, Wyoming, MI Assistant Clinical
More informationPathology of Vulnerable Plaque Angioplasty Summit 2005 TCT Asia Pacific, Seoul, April 28-30, 2005
Pathology of Vulnerable Plaque Angioplasty Summit 25 TCT Asia Pacific, Seoul, April 28-3, 25 Renu Virmani, MD CVPath, A Research Service of the International Registry of Pathology Gaithersburg, MD Plaque
More informationMaking BTK Interventions more Durable: Are DES and DCB the answer? Thomas Zeller, MD
Making BTK Interventions more Durable: Are DES and DCB the answer? Thomas Zeller, MD Faculty Disclosure Thomas Zeller, MD For the 12 months preceding this presentation, I disclose the following types of
More informationThe Latest Experimental Results of Endothelialization with BuMA stent. Renu Virmani, MD CVPath Institute, Inc. Gaithersburg, Maryland, USA
The Latest Experimental Results of Endothelialization with BuMA stent Renu Virmani, MD CVPath Institute, Inc. Gaithersburg, Maryland, USA In Stent Re -stenosis [%] Neointimal Thickness [mm] A Great Success
More informationCLI Treatment Using Long and Scoring Balloons
CLI Treatment Using Long and Scoring Balloons Robert Beasley, MD Director of Vascular and Interven3onal Radiology Mount Sinai Medical Center Miami Beach, FL Disclosures Consultant/Advisory Board: Abbott
More informationRecent Advances in Peripheral Salvage
Recent Advances in Peripheral Salvage Dr Shaiful Azmi Yahaya, MD, MMed, FNHAM, FAsCC, FAPSIC Consultant Cardiologist and Peripheral Interventionist, Institut Jantung Negara Disclosure I am proctoring for
More informationDealing with Calcification in BTK Arteries: Is Lithoplasty the Answer?
Dealing with Calcification in BTK Arteries: Is Lithoplasty the Answer? Andrew Holden, MBChB, FRANZCR, EBIR Director of Interventional Radiology Auckland, New Zealand LINC 2017 January 25 th 2017 Disclosure
More informationCan IVUS Define Plaque Features that Impact Patient Care?
Can IVUS Define Plaque Features that Impact Patient Care? A Pichard L Satler, K Kent, R Waksman, W Suddath, N Bernardo, N Weissman, M Angelo, D Harrington, J Lindsay, J Panza. Washington Hospital Center
More informationRetrograde dorsalis pedis and posterior tibial artery access after failed antegrade angioplasty
Retrograde dorsalis pedis and posterior tibial artery access after failed antegrade angioplasty Poster No.: C-2067 Congress: ECR 2010 Type: Topic: Authors: Keywords: DOI: Scientific Exhibit Interventional
More informationWhen and how to use distal protection devices for lower extremity revascularization. Peter A. Schneider, MD Kaiser Foundation Hospital, Honolulu
When and how to use distal protection devices for lower extremity revascularization Peter A. Schneider, MD Kaiser Foundation Hospital, Honolulu Disclosure Peter A. Schneider Potential conflicts of interest
More informationAccess strategy for chronic total occlusions (CTOs) is crucial
Learn How Access Strategy Impacts Complex CTO Crossing Arthur C. Lee, MD The Cardiac & Vascular Institute, Gainesville, Florida VASCULAR DISEASE MANAGEMENT 2018;15(3):E19-E23. Key words: chronic total
More informationThe Lutonix BTK Clinical Trial Programme: Status Update and Real World Clinical Experience
The Lutonix BTK Clinical Trial Programme: Status Update and Real World Clinical Experience Dierk Scheinert, MD University Hospital Leipzig Leipzig, Germany Disclosure Speaker name: Dierk Scheinert I have
More informationEndovascular Therapy vs. Open Femoral Endarterectomy Rationale and Design of the Randomized PESTO Trial
Endovascular Therapy vs. Open Femoral Endarterectomy Rationale and Design of the Randomized PESTO Trial Prof. Thomas Zeller, MD Department Angiology Clinic for Cardiology and Angiology II University Heart-Center
More informationDrug-coated balloons in BTK:
Drug-coated balloons in BTK: Where do we stand and what are the open questions? Dr. Marc Bosiers LINC 2019 - Leipzig My disclosures x o I do not have any potential conflicts of interest to report o I have
More informationHydrodynamic boost: a novel re-entry technique in distal BTK vessel: when and how to do it
Hydrodynamic boost: a novel re-entry technique in distal BTK vessel: when and how to do it Roberto Ferraresi Peripheral Interventional Unit Bergamo Italy Disclosure Roberto Ferraresi, MD I have the following
More informationJohn E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division
John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John Campbell, MD For the 12 months preceding this CME activity,
More informationBiomechanics and Inflammation in Atherosclerotic Plaque Erosion and Plaque Rupture: Implications for Cardiovascular Events in Women
Biomechanics and Inflammation in Atherosclerotic Plaque Erosion and Plaque Rupture: Implications for Cardiovascular Events in Women Ian Campbell, Emory University Jonathan D. Suever, Emory University Lucas
More informationLeft main coronary artery (LMCA): The proximal segment
Anatomy and Pathology of Left main coronary artery G Nakazawa Tokai Univ. Kanagawa, Japan 1 Anatomy Difinition Left main coronary artery (LMCA): The proximal segment RCA AV LAD LM LCX of the left coronary
More informationPractical Point in Holistic Diabetic Foot Care 3 March 2016
Diabetic Foot Ulcer : Vascular Management Practical Point in Holistic Diabetic Foot Care 3 March 2016 Supapong Arworn, MD Division of Vascular and Endovascular Surgery Department of Surgery, Chiang Mai
More informationAlternative concepts for drug delivery in BTK arteries the LIMBO project
Alternative concepts for drug delivery in BTK arteries the LIMBO project Dierk Scheinert, MD Division of Interventional Angiology University Hospital Leipzig, Germany 1 Disclosure Speaker s name: Dierk
More informationIntervention for Lower Extremity PAD: When, why and what?! Robert F Cuff, MD FACS RVT RPVI
Intervention for Lower Extremity PAD: When, why and what?! Robert F Cuff, MD FACS RVT RPVI 1 Disclosures I have no financial disclosures related to this talk Objectives 1. Discuss indications for intervention
More informationThe Pathology of Neoatherosclerosis in Human Coronary Implants
Journal of the American College of Cardiology Vol. 57, No. 11, 2011 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2011.01.011
More informationPatterns of Vessel Calcification and Clinical Relevance
Patterns of Vessel Calcification and Clinical Relevance Michael R. Jaff, DO Paul and Phyllis Fireman Endowed Chair in Vascular Medicine Massachusetts General Hospital Professor of Medicine Harvard Medical
More informationThe present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio
The present status of selfexpanding and balloonexpandable tibial BMS and DES for CLI: Why and when to use Sean P Lyden MD Cleveland Clinic Cleveland, Ohio Disclosure Speaker name: Sean Lyden, MD I have
More informationApproach to the Patient with (suspected) Arterial Insufficiency Related Ulceration
Approach to the Patient with (suspected) Arterial Insufficiency Related Ulceration Elisa C. Taffe, MD, CWSP Vascular Medicine Medical Director Allegheny General Advanced Wound Healing and Lymphedema Center
More informationDiagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC
Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC Interventional Cardiologist/Endovascular Specialist Bradenton Cardiology Center Bradenton,
More informationLeg arteries : MANAGEMENT and STRATEGY
Leg arteries : MANAGEMENT and STRATEGY Prof E. Ducasse Unit of vascular surgery BORDEAUX ESVB May 14th 2011 BARD Symposium CLI : definition Fontaine Rutherford ABI Symptoms class category Asymptomatic
More informationAssessment of Vulnerable Plaque by IVUS and VH-IVUS
Assessment of Vulnerable Plaque by IVUS and VH-IVUS Akiko Maehara, MD Director of Intravascular Imaging & Physiology Core Laboratories Associate Director of MRI/MDCT Core Laboratory Cardiovascular Research
More informationEVALUATION OF THE VASCULAR STATUS OF DIABETIC WOUNDS Travis Littman, MD NorthWest Surgical Specialists
EVALUATION OF THE VASCULAR STATUS OF DIABETIC WOUNDS Travis Littman, MD NorthWest Surgical Specialists Nothing To Disclosure DISCLOSURES I have no outside conflicts of interest, financial incentives, or
More informationFabrizio Fanelli, MD, EBIR Director Vascular and Interventional Radiology Department "Careggi " University Hospital Florence - Italy
Don t Use Risky and Embolizing Drug Coated Balloons Below The Knee! Fabrizio Fanelli, MD, EBIR Director Vascular and Interventional Radiology Department "Careggi " University Hospital Florence - Italy
More informationUpdate on the Levant 2 Clinical Trial Programme. Dierk Scheinert, MD University Hospital Leipzig Leipzig, Germany
Update on the Levant 2 Clinical Trial Programme Dierk Scheinert, MD University Hospital Leipzig Leipzig, Germany Disclosure Speaker name: Dierk Scheinert I have the following potential conflicts of interest
More informationDo we really need a stent in long SFA lesions? No: DEB is the answer
Do we really need a stent in long SFA lesions? No: DEB is the answer Thomas Zeller, MD University Heart-Center Freiburg-Bad Krozingen Bad Krozingen Germany My Disclosures: Advisory Board: Medtronic-Invatec,
More informationCan We Identify Vulnerable Patients & Vulnerable Plaque?
Can We Identify Vulnerable Patients & Vulnerable Plaque? We Know Enough to Treat High-Risk Lesions? Takashi Akasaka, MD, PhD Department of Cardiovascular Medicine, Japan Disclosure Statement of Financial
More informationPathology of Coronary Artery Disease
Pathology of Coronary Artery Disease Seth J. Kligerman, MD Pathology of Coronary Artery Disease Seth Kligerman, MD Assistant Professor Medical Director of MRI University of Maryland Department of Radiology
More informationUpdate on the OPTIMIZE BTK Trial. Marianne Brodmann, MD Division of Angiology Medical University Graz, Austria
Update on the OPTIMIZE BTK Trial Marianne Brodmann, MD Division of Angiology Medical University Graz, Austria Disclosure Speaker name: Marianne Brodmann, MD... I have the following potential conflicts
More informationMichael K. W. Lichtenberg, MD, FESC Westfälische Wilhelms-Universität Münster. Dierk Scheinert, M.D. Universitätsklinikum Leipzig AöR
Michael K. W. Lichtenberg, MD, FESC Westfälische Wilhelms-Universität Münster Dierk Scheinert, M.D. Universitätsklinikum Leipzig AöR Disclosure Dierk Scheinert, MD Advisory Board /Consultant: Abbott, Biotronik,
More informationLatest Insights from the LEVANT II study and sub-group analysis
Latest Insights from the LEVANT II study and sub-group analysis Prof. Dr. med. Dierk Scheinert Division of Interventional Angiology University-Hospital Leipzig, Germany Conflicts of Interest Advisory Board
More informationCopyright HMP Communications
Ocelot With Wildcat in a Complicated Superficial Femoral Artery Chronic Total Occlusion Soundos K. Moualla, MD, FACC, FSCAI; Richard R. Heuser, MD, FACC, FACP, FESC, FSCAI From Phoenix Heart Center, Phoenix,
More informationNovel concept for drug delivery in infrapopliteal arteries The LIMBO trial
Novel concept for drug delivery in infrapopliteal arteries The LIMBO trial Prof. Dr. med. Dierk Scheinert Division of Interventional Angiology University Hospital Leipzig, Germany 1 Disclosure Advisory
More informationNow That You Have the Tools
blockosu@gmail.com Now That You Have the Tools Alan Jay Block, DPM, MS, FASPS, FACFAS Assistant Professor Dept Of Orthopeadics The Ohio State University Medical Board Kent State University Editor-in -Chief
More informationThrombosis and Inflammation. What is the Next Target for New Drugs? CVPath Institute
Thrombosis and Inflammation in Plaque Vulnerability: What is the Next Target for New Drugs? Dr. Renu Virmani, MD CVPath Institute Gaithersburg, MD, USA Natural History of Atherosclerosis Systemic factors
More informationLessons & Perspectives: What is the role of Cryoplasty in SFA Intervention?
Lessons & Perspectives: What is the role of Cryoplasty in SFA Intervention? Michael Wholey, MD, MBA San Antonio, TX USA 19/06/2009 at 09:35 during 4mn as a Speaker Session: Improving Femoral Artery Recanalization
More informationDevice Evolution. Atherectomy: Where Do We Stand After 12 Years Since FDA Clearance. Where Do We Stand? 4/18/2015
Disclosure Statement of Financial Interest Atherectomy: Where Do We Stand After 12 Years Since FDA Clearance Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement
More informationThe Utility of Atherectomy and the Jetstream Atherectomy System
The Utility of Atherectomy and the Jetstream Atherectomy System William A. Gray, MD Columbia University Medical Center 2014 Boston Scientific Corporation or its affiliates. All rights reserved. IMPORTANT
More information6-month 0utcomes of a Novel Sirolimus Coated DCB Technology Evaluated in SFA Thomas Zeller, MD University Heart Center Freiburg-Bad Krozingen
First Report of the SELUTION Trial: 6-month 0utcomes of a Novel Sirolimus Coated DCB Technology Evaluated in SFA Thomas Zeller, MD University Heart Center Freiburg-Bad Krozingen On behalf of the SELUTION
More informationLutonix DCB in BTK Update on the BTK real world registry and RCT
Lutonix DCB in BTK Update on the BTK real world registry and RCT Prof. Dr. med. Dierk Scheinert Department of Interventional Angiology University Hospital Leipzig Disclosures Speaker: Prof. Dr. med. Dierk
More informationPulsar stent technology
Pulsar stent technology Michael K. W. Lichtenberg Vascular Center Arnsberg Disclosures Speaker name: Michael Lichtenberg... I have the following potential conflicts of interest to report: X Consulting
More informationLIBERTY 360 Study. 15-Jun-2018 Data 1. Olinic Dm, et al. Int Angiol. 2018;37:
LIBERTY 360 Study LIBERTY is a prospective, observational, multi-center study to evaluate procedural and long-term clinical and economic outcomes of endovascular device interventions in patients with symptomatic
More informationPeripheral artery disease (PAD) is a major cause of
Effective Debulking With the JETSTREAM System Strategies for effective treatment of PAD in the era of drug-coated balloons and contemporary stenting. BY THOMAS M. SHIMSHAK, MD, FACC, FSCAI Variable TABLE
More informationPeripheral Arterial Disease Extremity
Peripheral Arterial Disease Lower Extremity 05 Contributor Dr Steven Chong Advisors Dr Ashish Anil Dr Tay Jam Chin Introduction Risk Factors Clinical Presentation Classification History PHYSICAL examination
More informationThe BATTLE Trial Comparing Bare Metal to Drug Eluting Stents for Intermediate Length Lesions of the SFA
The BATTLE Trial Comparing Bare Metal to Drug Eluting Stents for Intermediate Length Lesions of the SFA BATTLE RCT investigators: Y. Gouëffic, A. Sauguet, P. Desgranges, P. Feugier, E. Rosset, E. Ducasse,
More informationSUPERSUB Trial: 1-yr outcomes of SUPERa SUBintimal stenting in CLI Patients
SUPERSUB Trial: 1-yr outcomes of SUPERa SUBintimal stenting in CLI Patients Dr. L.M. Palena, MD Interventional Radiology Unit Foot & Ankle Clinic Policlinico Abano Terme (PD), ITALY Disclosure I have the
More informationMaximizing Outcomes in a complex population with Drug-coated balloon
Maximizing Outcomes in a complex population with Drug-coated balloon March 13, 2018 Chumpol Wongwanit, MD Siriraj Hospital, Mahidol University, Bangkok, Thailand LINC Asia-Pacific 2018, Hong Kong Disclosure
More informationImaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging
Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging Gary S. Mintz,, MD Cardiovascular Research Foundation New York, NY Today, in reality, almost everything
More informationDCB in my practice: How the evidence influences my strategy. Yang-Jin Park
DCB in my practice: How the evidence influences my strategy Yang-Jin Park Associate Professor Division of Vascular Surgery, Department of Surgery Samsung Medical Center Sungkyunkwan University School of
More informationIs there still any space left for DES in the BTK area??? (Angiolite BTK trial, 6 month Data)
Is there still any space left for DES in the BTK area??? (Angiolite BTK trial, 6 month Data) (Angiolite BTK DES, IVascular) P. Goverde MD, K. Taeymans MD, K. Lauwers MD Vascular Clinic ZNA Antwerp,Belgium
More informationChapter 43 Noninvasive Coronary Plaque Imaging
hapter 43 Noninvasive oronary Plaque Imaging NIRUDH KOHLI The goal of coronary imaging is to define the extent of luminal narrowing as well as composition of an atherosclerotic plaque to facilitate appropriate
More informationPeripheral arterial disease for primary care Ed Aboian, MD
Peripheral arterial disease for primary care Ed Aboian, MD Division of Vascular and Endovascular Surgery Palo Alto Medical Foundation, Burlingame Ca Disclosures Nothing to disclose Clinical presentation
More informationWhy and where do I use mechanical debulking for the treatment of arterial occlusions?
Why and where do I use mechanical debulking for the treatment of arterial occlusions? Prof. Thomas Zeller Department Angiology University Heart-Center Freiburg - Bad Krozingen Bad Krozingen, Germany Faculty
More informationAppropriate Device Selection for Endovascular Procedures
Appropriate Device Selection for Endovascular Procedures Thomas M. Shimshak, MD Florida Hospital Heartland Medical Center Sebring, Florida Disclosures Speaker s Bureau: Abbott Vascular Boston Scientific
More informationUpdate on Tack Optimized Balloon Angioplasty (TOBA) Below the Knee. Marianne Brodmann, MD Medical University Graz Graz, Austria
Update on Tack Optimized Balloon Angioplasty (TOBA) Below the Knee Marianne Brodmann, MD Medical University Graz Graz, Austria Critical Limb Ischemia Infrapopliteal arterial disease is a leading source
More informationNeoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment
European Heart Journal (2015) 36, 2147 2159 doi:10.1093/eurheartj/ehv205 REVIEW Imaging Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment Fumiyuki
More informationWhen is below-the-ankle angioplasty indicated and how to introduce it into your practice. Roberto Ferraresi. Peripheral Interventional Unit
When is below-the-ankle angioplasty indicated and how to introduce it into your practice Roberto Ferraresi Peripheral Interventional Unit Bergamo Italy www.robertoferraresi.it Disclosure Roberto Ferraresi,
More informationIn-Stent Restenosis: New Evidence From Laser + Drug Coated Balloons
In-Stent Restenosis: New Evidence From Laser + Drug Coated Balloons Ehrin J. Armstrong, MD MSc Director, Interventional Cardiology VA Eastern Colorado Healthcare System Associate Professor of Medicine
More informationDrug Elution, Data, and Decisions
Drug Elution, Data, and Decisions What the data tell us about how to integrate drug-eluting technology into our daily practice. BY GARY ANSEL, MD, AND JOHN A. PHILLIPS, MD The use of drug-eluting technology
More informationNew Evidence from Laser + Drug Coated Balloons for Treatment of In-Stent Restenosis
New Evidence from Laser + Drug Coated Balloons for Treatment of In-Stent Restenosis Ehrin J. Armstrong, MD MSc Director, Interventional Cardiology VA Eastern Colorado Healthcare System Associate Professor
More informationOptical Coherence Tomography for Intracoronary Imaging
Optical Coherence Tomography for Intracoronary Imaging Lorenz Räber Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University Hospital, Switzerland
More informationThere are multiple endovascular options for treatment
Peripheral Rotablator Atherectomy: The Below-the-Knee Approach to Address Calcium Head On Peripheral Rotablator s front-cutting, diamond-tipped burr provides stable rotation in calcified lesions. BY SONYA
More informationOCT Guided Atherectomy: Initial Results of the VISION Trial Using the Pantheris Catheter. Patrick Muck, MD
OCT Guided Atherectomy: Initial Results of the VISION Trial Using the Pantheris Catheter Patrick Muck, MD Chief, Division of Vascular Surgery Good Samaritan Hospital Cincinna
More informationPathology of the Vulnerable Plaque
Journal of the American College of Cardiology Vol. 47, No. 8 Suppl C 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.10.065
More informationVessel Preparation Prior to DCB and Stenting: How to Do It.
Vessel Preparation Prior to DCB and Stenting: How to Do It. LINC 2018 January 30 February 2, 2018 Leipzig, Germany Brian DeRubertis, MD, FACS Associate Professor of Surgery UCLA Division of Vascular Surgery
More informationEndovascular Intervention BtK Intervention in Patients with Chronic Dialysis
Endovascular Intervention BtK Intervention in Patients with Chronic Dialysis GB Danzi, MD Ospedale Maggiore Policlinico Milan Italy Disease Pattern in PAD Hypercholesterolemia Age ESRD Current smoking
More informationDirectional Atherectomy and Gender Outcomes in DEFINTIVE LE
Directional Atherectomy and Gender Outcomes in DEFINTIVE LE Lawrence A. Garcia MD, on behalf of the DEFINITIVE LE Investigators Chief, Section Interventional Cardiology St. Elizabeth s Medical Center,
More informationMichael K. W. Lichtenberg MD, FESC on behalf of KANSHAS 1 investigators; Tepe G, Müller-Hülsbeck S, Deloose K, Verbist J, Goverde P, Zeller T
Interim 30-day analysis from the KANSHAS 1 study of the novel KANSHAS drug coated balloon for treatment of femoropopliteal occlusive disease; a latest first-in-human study Michael K. W. Lichtenberg MD,
More informationPromise and limitations of DCB in long lesions What Have we Learned from Clinical Trials? Ramon L. Varcoe, MBBS, MS, FRACS, PhD
Promise and limitations of DCB in long lesions What Have we Learned from Clinical Trials? Ramon L. Varcoe, MBBS, MS, FRACS, PhD Associate Professor of Vascular Surgery University of New South Wales Sydney,
More informationForget about the angiosome theories. Yann Gouëffic, MD, PhD Department of vascular surgery, institut du thorax, Nantes, France
Forget about the angiosome theories Yann Gouëffic, MD, PhD Department of vascular surgery, institut du thorax, Nantes, France Disclosure of Interest Research grants /Consulting/Honoraria for - Abbott -
More informationLessons learnt from DES in the SFA is there any ideal concept so far?
Wednesday, January 25, 2017 - Time: 11:49-11:55 DEEP DIVE SESSION: Lower limb interventions (part II) Lessons learnt from DES in the SFA is there any ideal concept so far? S.Müller-Hülsbeck, MD, EBIR,
More informationBlood Vessels. Dr. Nabila Hamdi MD, PhD
Blood Vessels Dr. Nabila Hamdi MD, PhD ILOs Understand the structure and function of blood vessels. Discuss the different mechanisms of blood pressure regulation. Compare and contrast the following types
More informationAngiosome revascularization strategies in real world practice: how much difference does it make?
Angiosome revascularization strategies in real world practice: how much difference does it make? Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii Disclosure Peter A. Schneider... I have
More informationI am no good at debates!
Disclosure Statement of Financial Interest Imaging Strategy for Claudication: Ultrasound Alone is Not Adequate to Select Patients for Endovascular Intervention Within the past 12 months, I or my spouse/partner
More informationIVUS Guided Case Review Case Performed by Frank R. Arko III, MD Charlotte, NC
IVUS Guided Case Review Case Performed by Frank R. Arko III, MD Charlotte, NC The opinions and clinical experiences presented herein are for informational purposes only. Dr. Arko is a paid consultant for
More informationMichael K.W. Lichtenberg, MD
Ranger All-Comer Registry Treatment of femoropopliteal atherosclerotic lesions using the Drug eluting Balloon Ranger: An All Comers Registry Michael K.W. Lichtenberg, MD Klinikum Arnsberg Arnsberg, Germany
More informationPlaque Characteristics in Coronary Artery Disease. Chourmouzios Arampatzis MD, PhD, FESC
Plaque Characteristics in Coronary Artery Disease Chourmouzios Arampatzis MD, PhD, FESC Disclosure Statement of Financial Interest Regarding this Presentation NONE Atherosclerosis Model proposed by Stary
More informationDisclosures. Tips and Tricks for Tibial Intervention. Tibial intervention overview
Tips and Tricks for Tibial Intervention Donald L. Jacobs, MD C Rollins Hanlon Endowed Professor and Chair Chair of Surgery Saint Louis University SSM-STL Saint Louis University Hospital Disclosures Abbott
More informationManaging Conditions Resulting from Untreated Cardiometabolic Syndrome
Managing Conditions Resulting from Untreated Cardiometabolic Syndrome Matthew P. Namanny DO, FACOS Vascular/Endovascular Surgery Saguaro Surgical/AZ Vascular Specialist Tucson Medical Center Critical Limb
More informationHybrid Heparin-Bonded Nitinol and eptfe Stent in the treatment of popliteal artery occlusion: mid- term follow-up results.
Hybrid Heparin-Bonded Nitinol and eptfe Stent in the treatment of popliteal artery occlusion: mid- term follow-up results. Wronski J. 1), 2) 3), Wilczynski M 1), Gembal P 1), Milik K 1), Dec St 1), Grybos
More informationImaging Atheroma The quest for the Vulnerable Plaque
Imaging Atheroma The quest for the Vulnerable Plaque P.J. de Feijter 1. Department of Cardiology 2. Department of Radiology Coronary Heart Disease Remains the Leading Cause of Death in the U.S, Causing
More informationThree main types of vascular calcification have been
ATVB in Focus Vascular Calcification: Basic Mechanisms to Clinical Perspectives Series Editors: Ann Marie Schmidt and Renu Virmani Has Our Understanding of Calcification in Human Coronary Atherosclerosis
More informationPreliminary 6-month results of VMI-CFA trial
Preliminary 6-month results of VMI-CFA trial Koen Deloose, MD Head Vascular Surgery, AZ Sint Blasius, Dendermonde, Belgium Disclosure slide Speaker name: Koen Deloose, MD I have the following potential
More informationRotarex mechanical debulking: The Leipzig experience in patients
Rotarex mechanical debulking: The Leipzig experience in 1.200+ patients Dierk Scheinert, MD Division of Interventional Angiology University-Hospital Leipzig, Germany Disclosure Speaker name: Dierk Scheinert
More informationCalcium Removal and Plaque Modification in the Era of DEB and Contemporary Stenting for Femoro- Popliteal Disease
Calcium Removal and Plaque Modification in the Era of DEB and Contemporary Stenting for Femoro- Popliteal Disease Thomas M. Shimshak, MD Heart and Vascular Center Florida Hospital Heartland Medical Center
More information